Seth Love - Publications

Affiliations: 
Neuropathology Frenchay Hospital, Bristol, England, United Kingdom 

159 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Tayler H, Miners JS, Güzel Ö, MacLachlan R, Love S. Mediators of cerebral hypoperfusion and blood-brain barrier leakiness in alzheimer's disease, vascular dementia and mixed dementia. Brain Pathology (Zurich, Switzerland). e12935. PMID 33410232 DOI: 10.1111/bpa.12935  0.32
2020 Lauwers E, Lalli G, Brandner S, Collinge J, Compernolle V, Duyckaerts C, Edgren G, Haïk S, Hardy J, Helmy A, Ivinson AJ, Jaunmuktane Z, Jucker M, Knight R, Lemmens R, ... ... Love S, et al. Potential human transmission of amyloid β pathology: surveillance and risks. The Lancet. Neurology. 19: 872-878. PMID 32949547 DOI: 10.1016/S1474-4422(20)30238-6  0.373
2020 Pennington C, Marini L, Coulthard E, Love S. Mixed neuropathology in frontotemporal lobar degeneration. Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration. 1-8. PMID 32116039 DOI: 10.1080/21678421.2020.1733019  0.336
2020 Ling H, Gelpi E, Davey K, Jaunmuktane Z, Mok KY, Jabbari E, Simone R, R'Bibo L, Brandner S, Ellis MJ, Attems J, Mann D, Halliday GM, Al-Sarraj S, Hedreen J, ... ... Love S, et al. Fulminant corticobasal degeneration: a distinct variant with predominant neuronal tau aggregates. Acta Neuropathologica. PMID 31950334 DOI: 10.1007/S00401-019-02119-4  0.352
2020 Palmer JC, Tayler HM, Dyer L, Kehoe PG, Paton JFR, Love S. Zibotentan, an Endothelin Alzheimer's Disease Receptor Antagonist, Prevents Amyloid-β-Induced Hypertension and Maintains Cerebral Perfusion. Journal of Alzheimer's Disease : Jad. PMID 31903990 DOI: 10.3233/Jad-190630  0.357
2019 Miners JS, Kehoe PG, Love S, Zetterberg H, Blennow K. CSF evidence of pericyte damage in Alzheimer's disease is associated with markers of blood-brain barrier dysfunction and disease pathology. Alzheimer's Research & Therapy. 11: 81. PMID 31521199 DOI: 10.1186/S13195-019-0534-8  0.383
2019 Sinclair LI, Kumar A, Darreh-Shori T, Love S. Visual hallucinations in Alzheimer's disease do not seem to be associated with chronic hypoperfusion of to visual processing areas V2 and V3 but may be associated with reduced cholinergic input to these areas. Alzheimer's Research & Therapy. 11: 80. PMID 31511061 DOI: 10.1186/S13195-019-0519-7  0.346
2019 Nicoll JAR, Buckland GR, Harrison CH, Page A, Harris S, Love S, Neal JW, Holmes C, Boche D. Persistent neuropathological effects 14 years following amyloid-β immunization in Alzheimer's disease. Brain : a Journal of Neurology. PMID 31157360 DOI: 10.1093/Brain/Awz142  0.402
2019 Sweeney MD, Montagne A, Sagare AP, Nation DA, Schneider LS, Chui HC, Harrington MG, Pa J, Law M, Wang DJJ, Jacobs RE, Doubal FN, Ramirez J, Black SE, Nedergaard M, ... ... Love S, et al. Vascular dysfunction-The disregarded partner of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association. 15: 158-167. PMID 30642436 DOI: 10.1016/J.Jalz.2018.07.222  0.412
2018 Rakic S, Hung YMA, Smith M, So D, Tayler HM, Varney W, Wild J, Harris S, Holmes C, Love S, Stewart W, Nicoll JAR, Boche D. Systemic infection modifies the neuroinflammatory response in late stage Alzheimer's disease. Acta Neuropathologica Communications. 6: 88. PMID 30193587 DOI: 10.1186/S40478-018-0592-3  0.317
2018 Coulthard EJ, Love S. A broader view of dementia: multiple co-pathologies are the norm. Brain : a Journal of Neurology. 141: 1894-1897. PMID 30053176 DOI: 10.1093/Brain/Awy153  0.317
2018 Horsburgh K, Wardlaw JM, van Agtmael T, Allan SM, Ashford MLJ, Bath PM, Brown R, Berwick J, Cader MZ, Carare RO, Davis JB, Duncombe J, Farr TD, Fowler JH, Goense J, ... ... Love S, et al. Small vessels, dementia and chronic diseases - molecular mechanisms and pathophysiology. Clinical Science (London, England : 1979). 132: 851-868. PMID 29712883 DOI: 10.1042/Cs20171620  0.323
2017 Harris R, Miners JS, Allen S, Love S. VEGFR1 and VEGFR2 in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29226875 DOI: 10.3233/Jad-170745  0.36
2017 Hull J, Usmari Moraes M, Brookes E, Love S, Conway ME. Distribution of the branched-chain α-ketoacid dehydrogenase complex E1α subunit and glutamate dehydrogenase in the human brain and their role in neuro-metabolism. Neurochemistry International. PMID 29104034 DOI: 10.1016/J.Neuint.2017.10.014  0.307
2017 Hares K, Miners JS, Cook AJ, Rice C, Scolding N, Love S, Wilkins A. Overexpression of Kinesin Superfamily Motor Proteins in Alzheimer's Disease. Journal of Alzheimer's Disease : Jad. PMID 29060936 DOI: 10.3233/Jad-170094  0.403
2017 Paquet C, Nicoll JA, Love S, Mouton-Liger F, Holmes C, Hugon J, Boche D. DOWNREGULATED APOPTOSIS AND AUTOPHAGY AFTER ANTI-Aβ IMMUNOTHERAPY IN ALZHEIMER'S DISEASE. Brain Pathology (Zurich, Switzerland). PMID 29027727 DOI: 10.1111/Bpa.12567  0.401
2017 Tayler HM, Palmer JC, Thomas TL, Kehoe PG, Paton JF, Love S. Cerebral Aβ40 and systemic hypertension. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X17724930. PMID 28782443 DOI: 10.1177/0271678X17724930  0.331
2017 Sinclair LI, Love S. Effect of APOE Genotype on Synaptic Proteins in Earlier Adult Life. Journal of Alzheimer's Disease : Jad. PMID 28731446 DOI: 10.3233/Jad-170316  0.337
2017 Love S, Miners JS. Small vessel disease, neurovascular regulation and cognitive impairment: post-mortem studies reveal a complex relationship, still poorly understood. Clinical Science (London, England : 1979). 131: 1579-1589. PMID 28667060 DOI: 10.1042/Cs20170148  0.33
2017 Miners JS, Schulz I, Love S. Differing associations between Aβ accumulation, hypoperfusion, blood-brain barrier dysfunction and loss of PDGFRB pericyte marker in the precuneus and parietal white matter in Alzheimer's disease. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 271678X17690761. PMID 28151041 DOI: 10.1177/0271678X17690761  0.4
2016 Robinson AC, Palmer L, Love S, Hamard M, Esiri M, Ansorge O, Lett D, Attems J, Morris C, Troakes C, Selvackadunco S, King A, Al-Sarraj S, Mann DM. Extended post-mortem delay times should not be viewed as a deterrent to the scientific investigation of human brain tissue: a study from the Brains for Dementia Research Network Neuropathology Study Group, UK. Acta Neuropathologica. PMID 27638700 DOI: 10.1007/S00401-016-1617-2  0.308
2016 McAleese KE, Alafuzoff I, Charidimou A, De Reuck J, Grinberg LT, Hainsworth AH, Hortobagyi T, Ince P, Jellinger K, Gao J, Kalaria RN, Kovacs GG, Kövari E, Love S, Popovic M, et al. Post-mortem assessment in vascular dementia: advances and aspirations. Bmc Medicine. 14: 129. PMID 27600683 DOI: 10.1186/S12916-016-0676-5  0.323
2016 Skrobot OA, Attems J, Esiri M, Hortobágyi T, Ironside JW, Kalaria RN, King A, Lammie GA, Mann D, Neal J, Ben-Shlomo Y, Kehoe PG, Love S. Vascular cognitive impairment neuropathology guidelines (VCING): the contribution of cerebrovascular pathology to cognitive impairment. Brain : a Journal of Neurology. PMID 27591113 DOI: 10.1093/Brain/Aww214  0.304
2016 Love S, Miners JS. Cerebral hypoperfusion and the energy deficit in Alzheimer's disease. Brain Pathology (Zurich, Switzerland). PMID 27327656 DOI: 10.1111/Bpa.12401  0.404
2016 Miners JS, Clarke P, Love S. Clusterin levels are increased in Alzheimer's disease and influence the regional distribution of Aβ. Brain Pathology (Zurich, Switzerland). PMID 27248362 DOI: 10.1111/Bpa.12392  0.391
2016 Ashby EL, Miners JS, Kehoe PG, Love S. Effects of Hypertension and Anti-Hypertensive Treatment on Amyloid-β (Aβ) Plaque Load and Aβ-Synthesizing and Aβ-Degrading Enzymes in Frontal Cortex. Journal of Alzheimer's Disease : Jad. 50: 1191-203. PMID 26836178 DOI: 10.3233/Jad-150831  0.305
2016 Charidimou A, Pantoni L, Love S. The concept of sporadic cerebral small vessel disease: A road map on key definitions and current concepts. International Journal of Stroke. 11: 6-18. PMID 26763016 DOI: 10.1177/1747493015607485  0.334
2016 Sinclair L, Love S. Do synaptic changes occur before old age in people at high genetic risk of Alzheimer's disease? The Lancet. 387. DOI: 10.1016/S0140-6736(16)00479-7  0.335
2016 Love S, Miners JS. Cerebrovascular disease in ageing and Alzheimer’s disease Acta Neuropathologica. 131: 645-658. DOI: 10.1007/S00401-015-1522-0  0.41
2015 Love S, Miners JS. Cerebrovascular disease in ageing and Alzheimer's disease. Acta Neuropathologica. 131: 645-58. PMID 26711459 DOI: 10.1007/s00401-015-1522-0  0.301
2015 Kovacs GG, Ferrer I, Grinberg LT, Alafuzoff I, Attems J, Budka H, Cairns NJ, Crary JF, Duyckaerts C, Ghetti B, Halliday GM, Ironside JW, Love S, Mackenzie IR, Munoz DG, et al. Aging-related tau astrogliopathy (ARTAG): harmonized evaluation strategy. Acta Neuropathologica. PMID 26659578 DOI: 10.1007/S00401-015-1509-X  0.354
2015 Miners JS, Palmer JC, Love S. Pathophysiology of hypoperfusion of the precuneus in early Alzheimer's disease. Brain Pathology (Zurich, Switzerland). PMID 26452729 DOI: 10.1111/Bpa.12331  0.404
2015 Slevin M, Matou S, Zeinolabediny Y, Corpas R, Weston R, Liu D, Boras E, Di Napoli M, Petcu E, Sarroca S, Popa-Wagner A, Love S, Font MA, Potempa LA, Al-Baradie R, et al. Monomeric C-reactive protein--a key molecule driving development of Alzheimer's disease associated with brain ischaemia? Scientific Reports. 5: 13281. PMID 26335098 DOI: 10.1038/Srep13281  0.411
2015 Jun G, Ibrahim-Verbaas CA, Vronskaya M, Lambert JC, Chung J, Naj AC, Kunkle BW, Wang LS, Bis JC, Bellenguez C, Harold D, Lunetta KL, Destefano AL, Grenier-Boley B, Sims R, ... ... Love S, et al. A novel Alzheimer disease locus located near the gene encoding tau protein. Molecular Psychiatry. PMID 25778476 DOI: 10.1038/Mp.2015.23  0.329
2015 Thomas T, Miners S, Love S. Post-mortem assessment of hypoperfusion of cerebral cortex in Alzheimer's disease and vascular dementia. Brain : a Journal of Neurology. 138: 1059-69. PMID 25688080 DOI: 10.1093/Brain/Awv025  0.4
2015 Hull J, Patel V, El Hindy M, Lee C, Odeleye E, Hezwani M, Love S, Kehoe P, Chalmers K, Conway M. Regional Increase in the Expression of the BCAT Proteins in Alzheimer's Disease Brain: Implications in Glutamate Toxicity. Journal of Alzheimer's Disease : Jad. 45: 891-905. PMID 25633671 DOI: 10.3233/Jad-142970  0.403
2015 Sinclair LI, Tayler HM, Love S. Synaptic protein levels altered in vascular dementia. Neuropathology and Applied Neurobiology. 41: 533-43. PMID 25559750 DOI: 10.1111/Nan.12215  0.368
2015 Ashby EL, Miners JS, Kumar S, Walter J, Love S, Kehoe PG. Investigation of Aβ phosphorylated at serine 8 (pAβ) in Alzheimer's disease, dementia with Lewy bodies and vascular dementia. Neuropathology and Applied Neurobiology. 41: 428-44. PMID 25556395 DOI: 10.1111/Nan.12212  0.415
2015 Amin J, Paquet C, Baker A, Asuni AA, Love S, Holmes C, Hugon J, Nicoll JA, Boche D. Effect of amyloid-β (Aβ) immunization on hyperphosphorylated tau: a potential role for glycogen synthase kinase (GSK)-3β. Neuropathology and Applied Neurobiology. 41: 445-57. PMID 25486988 DOI: 10.1111/Nan.12205  0.32
2015 Paquet C, Amin J, Mouton-Liger F, Nasser M, Love S, Gray F, Pickering RM, Nicoll JA, Holmes C, Hugon J, Boche D. Effect of active Aβ immunotherapy on neurons in human Alzheimer's disease. The Journal of Pathology. 235: 721-30. PMID 25430817 DOI: 10.1002/Path.4491  0.375
2015 Graham SF, Nasarauddin MB, Carey M, McGuinness B, Holscher C, Kehoe PG, Love S, Passmore AP, Elliott CT, Meharg A, Green BD. Quantitative measurement of [Na+] and [K+] in postmortem human brain tissue indicates disturbances in subjects with Alzheimer's disease and dementia with Lewy bodies. Journal of Alzheimer's Disease : Jad. 44: 851-7. PMID 25362038 DOI: 10.3233/Jad-141869  0.373
2015 Maxwell A, Archer H, Cohen N, Love S, Cottrell D. Progressive Multifocal Leucoencephalopathy: An Atypical Case Journal of Neurology, Neurosurgery, and Psychiatry. 86. DOI: 10.1136/Jnnp-2015-312379.90  0.306
2014 Swirski M, Miners JS, de Silva R, Lashley T, Ling H, Holton J, Revesz T, Love S. Evaluating the relationship between amyloid-β and α-synuclein phosphorylated at Ser129 in dementia with Lewy bodies and Parkinson's disease. Alzheimer's Research & Therapy. 6: 77. PMID 25452767 DOI: 10.1186/S13195-014-0077-Y  0.307
2014 Miners JS, Palmer JC, Tayler H, Palmer LE, Ashby E, Kehoe PG, Love S. Aβ degradation or cerebral perfusion? Divergent effects of multifunctional enzymes. Frontiers in Aging Neuroscience. 6: 238. PMID 25309424 DOI: 10.3389/Fnagi.2014.00238  0.375
2014 Sakai K, Boche D, Carare R, Johnston D, Holmes C, Love S, Nicoll JA. Aβ immunotherapy for Alzheimer's disease: effects on apoE and cerebral vasculopathy. Acta Neuropathologica. 128: 777-89. PMID 25195061 DOI: 10.1007/S00401-014-1340-9  0.399
2014 Graham SF, Nasaruddin MB, Carey M, Holscher C, McGuinness B, Kehoe PG, Love S, Passmore P, Elliott CT, Meharg AA, Green BD. Age-associated changes of brain copper, iron, and zinc in Alzheimer's disease and dementia with Lewy bodies. Journal of Alzheimer's Disease : Jad. 42: 1407-13. PMID 25024342 DOI: 10.3233/Jad-140684  0.366
2014 Escott-Price V, Bellenguez C, Wang LS, Choi SH, Harold D, Jones L, Holmans P, Gerrish A, Vedernikov A, Richards A, DeStefano AL, Lambert JC, Ibrahim-Verbaas CA, Naj AC, Sims R, ... ... Love S, et al. Gene-wide analysis detects two new susceptibility genes for Alzheimer's disease. Plos One. 9: e94661. PMID 24922517 DOI: 10.1371/Journal.Pone.0094661  0.337
2014 Barker R, Ashby EL, Wellington D, Barrow VM, Palmer JC, Kehoe PG, Esiri MM, Love S. Pathophysiology of white matter perfusion in Alzheimer's disease and vascular dementia. Brain : a Journal of Neurology. 137: 1524-32. PMID 24618270 DOI: 10.1093/Brain/Awu040  0.344
2014 Miners S, Moulding H, de Silva R, Love S. Reduced vascular endothelial growth factor and capillary density in the occipital cortex in dementia with Lewy bodies. Brain Pathology (Zurich, Switzerland). 24: 334-43. PMID 24521289 DOI: 10.1111/Bpa.12130  0.312
2014 Miners JS, Jones R, Love S. Differential changes in Aβ42 and Aβ40 with age. Journal of Alzheimer's Disease : Jad. 40: 727-35. PMID 24503618 DOI: 10.3233/Jad-132339  0.397
2014 Barua NU, Gill SS, Love S. Convection-enhanced drug delivery to the brain: therapeutic potential and neuropathological considerations. Brain Pathology (Zurich, Switzerland). 24: 117-27. PMID 23944716 DOI: 10.1111/Bpa.12082  0.315
2013 Glennon EB, Whitehouse IJ, Miners JS, Kehoe PG, Love S, Kellett KA, Hooper NM. BIN1 is decreased in sporadic but not familial Alzheimer's disease or in aging. Plos One. 8: e78806. PMID 24205320 DOI: 10.1371/Journal.Pone.0078806  0.399
2013 Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C, DeStafano AL, Bis JC, Beecham GW, Grenier-Boley B, Russo G, Thorton-Wells TA, Jones N, Smith AV, Chouraki V, ... ... Love S, et al. Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease. Nature Genetics. 45: 1452-8. PMID 24162737 DOI: 10.1038/Ng.2802  0.334
2013 Zotova E, Bharambe V, Cheaveau M, Morgan W, Holmes C, Harris S, Neal JW, Love S, Nicoll JA, Boche D. Inflammatory components in human Alzheimer's disease and after active amyloid-β42 immunization. Brain : a Journal of Neurology. 136: 2677-96. PMID 23943781 DOI: 10.1093/Brain/Awt210  0.366
2013 Palmer JC, Tayler HM, Love S. Endothelin-converting enzyme-1 activity, endothelin-1 production, and free radical-dependent vasoconstriction in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 36: 577-87. PMID 23629587 DOI: 10.3233/Jad-130383  0.398
2013 Whitehouse IJ, Miners JS, Glennon EB, Kehoe PG, Love S, Kellett KA, Hooper NM. Prion protein is decreased in Alzheimer's brain and inversely correlates with BACE1 activity, amyloid-β levels and Braak stage. Plos One. 8: e59554. PMID 23577068 DOI: 10.1371/Journal.Pone.0059554  0.378
2013 Barker R, Wellington D, Esiri MM, Love S. Assessing white matter ischemic damage in dementia patients by measurement of myelin proteins. Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism. 33: 1050-7. PMID 23532085 DOI: 10.1038/Jcbfm.2013.46  0.366
2013 Ruzali WA, Kehoe PG, Love S. Influence of LRP-1 and apolipoprotein E on amyloid-β uptake and toxicity to cerebrovascular smooth muscle cells. Journal of Alzheimer's Disease : Jad. 33: 95-110. PMID 22914594 DOI: 10.3233/Jad-2012-121336  0.347
2013 Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, ... ... Love S, et al. Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nature Genetics. 45: 712-712. DOI: 10.1038/Ng0613-712A  0.312
2013 Boche D, Amin J, Mouton-Liger F, Nasser M, Love S, Gray F, Pickering R, Nicoll J, Holmes C, Hugon J, Paquet C. Consequences of beta-amyloid immunotherapy for Alzheimer's disease on neurons in the human cerebral cortex Alzheimers & Dementia. 9: 284. DOI: 10.1016/J.Jalz.2013.05.571  0.348
2013 Boche D, Zotova E, Bharambe V, Cheaveau M, Morgan W, Holmes C, Harris S, Neal J, Love S, Nicoll J. Characterizing inflammatory components in human Alzheimer's disease and following active beta-amyloid 42 immunization Alzheimers & Dementia. 9. DOI: 10.1016/J.Jalz.2013.05.570  0.324
2013 Nicoll J, Sakai K, Love S, Boche D. Cerebral amyloid angiopathy-associated vasculopathy and apolipoprotein E accumulation after beta-amyloid immunotherapy for Alzheimer's disease Alzheimers & Dementia. 9: 529. DOI: 10.1016/J.Jalz.2013.04.268  0.366
2012 Weir HJ, Murray TK, Kehoe PG, Love S, Verdin EM, O'Neill MJ, Lane JD, Balthasar N. CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer's disease. Plos One. 7: e48225. PMID 23139766 DOI: 10.1371/Journal.Pone.0048225  0.346
2012 Ruzali WA, Kehoe PG, Love S. LRP1 expression in cerebral cortex, choroid plexus and meningeal blood vessels: relationship to cerebral amyloid angiopathy and APOE status. Neuroscience Letters. 525: 123-8. PMID 22967844 DOI: 10.1016/J.Neulet.2012.07.065  0.396
2012 Barua NU, Miners JS, Bienemann AS, Wyatt MJ, Welser K, Tabor AB, Hailes HC, Love S, Gill SS. Convection-enhanced delivery of neprilysin: a novel amyloid-β-degrading therapeutic strategy. Journal of Alzheimer's Disease : Jad. 32: 43-56. PMID 22751177 DOI: 10.3233/Jad-2012-120658  0.381
2012 Love S. Resistant to amyloid-β or just waiting for disease to happen? Alzheimer's Research & Therapy. 4: 19. PMID 22643124 DOI: 10.1186/Alzrt122  0.419
2012 Nelson PT, Alafuzoff I, Bigio EH, Bouras C, Braak H, Cairns NJ, Castellani RJ, Crain BJ, Davies P, Del Tredici K, Duyckaerts C, Frosch MP, Haroutunian V, Hof PR, Hulette CM, ... ... Love S, et al. Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature. Journal of Neuropathology and Experimental Neurology. 71: 362-81. PMID 22487856 DOI: 10.1097/Nen.0B013E31825018F7  0.378
2012 Gilkes CE, Love S, Hardie RJ, Edwards RJ, Scolding NJ, Rice CM. Brain biopsy in benign neurological disease. Journal of Neurology. 259: 995-1000. PMID 22361977 DOI: 10.1007/S00415-012-6455-0  0.325
2012 Palmer JC, Barker R, Kehoe PG, Love S. Endothelin-1 is elevated in Alzheimer's disease and upregulated by amyloid-β. Journal of Alzheimer's Disease : Jad. 29: 853-61. PMID 22330820 DOI: 10.3233/Jad-2012-111760  0.394
2012 Baig S, Palmer LE, Owen MJ, Williams J, Kehoe PG, Love S. Clusterin mRNA and protein in Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 28: 337-44. PMID 22232000 DOI: 10.3233/Jad-2011-110473  0.397
2012 Gerrish A, Russo G, Richards A, Moskvina V, Ivanov D, Harold D, Sims R, Abraham R, Hollingworth P, Chapman J, Hamshere M, Pahwa JS, Dowzell K, Williams A, Jones N, ... ... Love S, et al. The role of variation at AβPP, PSEN1, PSEN2, and MAPT in late onset Alzheimer's disease. Journal of Alzheimer's Disease : Jad. 28: 377-87. PMID 22027014 DOI: 10.3233/Jad-2011-110824  0.373
2012 Barker R, Kehoe PG, Love S. Activators and inhibitors of the plasminogen system in Alzheimer's disease. Journal of Cellular and Molecular Medicine. 16: 865-76. PMID 21790972 DOI: 10.1111/J.1582-4934.2011.01394.X  0.375
2012 Ashby EL, Love S, Kehoe PG. Assessment of activation of the plasma kallikrein-kinin system in frontal and temporal cortex in Alzheimer's disease and vascular dementia. Neurobiology of Aging. 33: 1345-55. PMID 21074291 DOI: 10.1016/J.Neurobiolaging.2010.09.024  0.392
2011 Miners JS, Barua N, Kehoe PG, Gill S, Love S. Aβ-degrading enzymes: potential for treatment of Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 70: 944-59. PMID 22002425 DOI: 10.1097/Nen.0B013E3182345E46  0.367
2011 Love S, Spillantini MG. Unpicking frontotemporal lobar degeneration. Brain : a Journal of Neurology. 134: 2453-5. PMID 21859768 DOI: 10.1093/Brain/Awr176  0.345
2011 Sims R, Dwyer S, Harold D, Gerrish A, Hollingworth P, Chapman J, Jones N, Abraham R, Ivanov D, Pahwa JS, Moskvina V, Dowzell K, Thomas C, Stretton A, Lovestone S, ... ... Love S, et al. No evidence that extended tracts of homozygosity are associated with Alzheimer's disease. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 156: 764-71. PMID 21812096 DOI: 10.1002/Ajmg.B.31216  0.366
2011 Miners JS, Kehoe P, Love S. Neprilysin protects against cerebral amyloid angiopathy and Aβ-induced degeneration of cerebrovascular smooth muscle cells. Brain Pathology (Zurich, Switzerland). 21: 594-605. PMID 21382117 DOI: 10.1111/J.1750-3639.2011.00486.X  0.399
2011 Palmer J, Love S. Endothelin receptor antagonists: potential in Alzheimer's disease. Pharmacological Research : the Official Journal of the Italian Pharmacological Society. 63: 525-31. PMID 21193044 DOI: 10.1016/J.Phrs.2010.12.008  0.401
2011 Miners JS, Morris S, Love S, Kehoe PG. Accumulation of insoluble amyloid-β in down's syndrome is associated with increased BACE-1 and neprilysin activities. Journal of Alzheimer's Disease : Jad. 23: 101-8. PMID 20930275 DOI: 10.3233/Jad-2010-101395  0.389
2011 Love S, Chalmers K, Esiri M, Ince P, Kehoe P. Validation of an internationally developed protocol to assess the distribution and severity of cerebral amyloid angiopathy in the post-mortem brain Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.09.170  0.324
2011 Zotova E, Holmes C, Neal J, Love S, Nicoll J, Boche D. Lower microglial Fcγ RI/II and macrophage scavenger receptor a in human Alzheimer's disease after Aβ42 immunisation. Alzheimers & Dementia. 7. DOI: 10.1016/J.Jalz.2011.05.1976  0.334
2010 Chalmers KA, Barker R, Passmore PA, Panza F, Seripa D, Solfrizzi V, Love S, Prince JA, Kehoe PG. LRP-1 variation is not associated with risk of Alzheimer's disease. International Journal of Molecular Epidemiology and Genetics. 1: 104-13. PMID 21537384  0.301
2010 Jones L, Holmans PA, Hamshere ML, Harold D, Moskvina V, Ivanov D, Pocklington A, Abraham R, Hollingworth P, Sims R, Gerrish A, Pahwa JS, Jones N, Stretton A, Morgan AR, ... ... Love S, et al. Genetic evidence implicates the immune system and cholesterol metabolism in the aetiology of Alzheimer's disease. Plos One. 5: e13950. PMID 21085570 DOI: 10.1371/Journal.Pone.0013950  0.314
2010 Tayler H, Fraser T, Miners JS, Kehoe PG, Love S. Oxidative balance in Alzheimer's disease: relationship to APOE, Braak tangle stage, and the concentrations of soluble and insoluble amyloid-β. Journal of Alzheimer's Disease : Jad. 22: 1363-73. PMID 20930272 DOI: 10.3233/Jad-2010-101368  0.397
2010 Ashby EL, Kehoe PG, Love S. Kallikrein-related peptidase 6 in Alzheimer's disease and vascular dementia. Brain Research. 1363: 1-10. PMID 20846516 DOI: 10.1016/J.Brainres.2010.09.017  0.416
2010 Baig S, Joseph SA, Tayler H, Abraham R, Owen MJ, Williams J, Kehoe PG, Love S. Distribution and expression of picalm in Alzheimer disease. Journal of Neuropathology and Experimental Neurology. 69: 1071-7. PMID 20838239 DOI: 10.1097/Nen.0B013E3181F52E01  0.367
2010 Barker R, Love S, Kehoe PG. Plasminogen and plasmin in Alzheimer's disease. Brain Research. 1355: 7-15. PMID 20709033 DOI: 10.1016/J.Brainres.2010.08.025  0.41
2010 Boche D, Donald J, Love S, Harris S, Neal JW, Holmes C, Nicoll JA. Reduction of aggregated Tau in neuronal processes but not in the cell bodies after Abeta42 immunisation in Alzheimer's disease. Acta Neuropathologica. 120: 13-20. PMID 20532897 DOI: 10.1007/S00401-010-0705-Y  0.421
2010 Palmer JC, Kehoe PG, Love S. Endothelin-converting enzyme-1 in Alzheimer's disease and vascular dementia. Neuropathology and Applied Neurobiology. 36: 487-97. PMID 20345647 DOI: 10.1111/J.1365-2990.2010.01084.X  0.418
2010 van Helmond Z, Miners JS, Kehoe PG, Love S. Higher soluble amyloid beta concentration in frontal cortex of young adults than in normal elderly or Alzheimer's disease. Brain Pathology (Zurich, Switzerland). 20: 787-93. PMID 20175777 DOI: 10.1111/J.1750-3639.2010.00374.X  0.357
2010 Miners JS, van Helmond Z, Kehoe PG, Love S. Changes with age in the activities of beta-secretase and the Abeta-degrading enzymes neprilysin, insulin-degrading enzyme and angiotensin-converting enzyme. Brain Pathology (Zurich, Switzerland). 20: 794-802. PMID 20175776 DOI: 10.1111/J.1750-3639.2010.00375.X  0.312
2010 Fraser T, Tayler H, Love S. Fatty acid composition of frontal, temporal and parietal neocortex in the normal human brain and in Alzheimer's disease. Neurochemical Research. 35: 503-13. PMID 19904605 DOI: 10.1007/S11064-009-0087-5  0.329
2010 van Helmond Z, Miners JS, Kehoe PG, Love S. Oligomeric Abeta in Alzheimer's disease: relationship to plaque and tangle pathology, APOE genotype and cerebral amyloid angiopathy. Brain Pathology (Zurich, Switzerland). 20: 468-80. PMID 19725829 DOI: 10.1111/J.1750-3639.2009.00321.X  0.367
2010 Boche D, Donald J, Love S, Neal JW, Holmes C, Nicoll J. Aβ42 immunization reduces both tau and Aβ deposits in Alzheimer's disease Alzheimers & Dementia. 6. DOI: 10.1016/J.Jalz.2010.05.2019  0.369
2009 Kehoe PG, Miners S, Love S. Angiotensins in Alzheimer's disease - friend or foe? Trends in Neurosciences. 32: 619-28. PMID 19796831 DOI: 10.1016/J.Tins.2009.07.006  0.343
2009 Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, ... ... Love S, et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease. Nature Genetics. 41: 1088-93. PMID 19734902 DOI: 10.1038/Ng.440  0.314
2009 Miners JS, Baig S, Tayler H, Kehoe PG, Love S. Neprilysin and insulin-degrading enzyme levels are increased in Alzheimer disease in relation to disease severity. Journal of Neuropathology and Experimental Neurology. 68: 902-14. PMID 19606063 DOI: 10.1097/Nen.0B013E3181Afe475  0.393
2009 Baig S, van Helmond Z, Love S. Tau hyperphosphorylation affects Smad 2/3 translocation. Neuroscience. 163: 561-70. PMID 19555739 DOI: 10.1016/J.Neuroscience.2009.06.045  0.377
2009 Palmer JC, Baig S, Kehoe PG, Love S. Endothelin-converting enzyme-2 is increased in Alzheimer's disease and up-regulated by Abeta. The American Journal of Pathology. 175: 262-70. PMID 19541930 DOI: 10.2353/Ajpath.2009.081054  0.424
2009 Love S, Miners S, Palmer J, Chalmers K, Kehoe P. Insights into the pathogenesis and pathogenicity of cerebral amyloid angiopathy. Frontiers in Bioscience (Landmark Edition). 14: 4778-92. PMID 19273389 DOI: 10.2741/3567  0.377
2009 Chalmers KA, Wilcock GK, Vinters HV, Perry EK, Perry R, Ballard CG, Love S. Cholinesterase inhibitors may increase phosphorylated tau in Alzheimer's disease. Journal of Neurology. 256: 717-20. PMID 19240967 DOI: 10.1007/S00415-009-5000-2  0.412
2009 Keage HA, Carare RO, Friedland RP, Ince PG, Love S, Nicoll JA, Wharton SB, Weller RO, Brayne C. Population studies of sporadic cerebral amyloid angiopathy and dementia: a systematic review. Bmc Neurology. 9: 3. PMID 19144113 DOI: 10.1186/1471-2377-9-3  0.328
2009 van Helmond Z, Heesom K, Love S. Characterisation of two antibodies to oligomeric Abeta and their use in ELISAs on human brain tissue homogenates. Journal of Neuroscience Methods. 176: 206-12. PMID 18824027 DOI: 10.1016/J.Jneumeth.2008.09.002  0.362
2009 Culpan D, Cram D, Chalmers K, Cornish A, Palmer L, Palmer J, Hughes A, Passmore P, Craig D, Craigs D, Wilcock GK, Kehoe PG, Love S. TNFR-associated factor-2 (TRAF-2) in Alzheimer's disease. Neurobiology of Aging. 30: 1052-60. PMID 18069092 DOI: 10.1016/J.Neurobiolaging.2007.10.014  0.392
2009 Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML, Pahwa JS, Moskvina V, Dowzell K, Williams A, Jones N, Thomas C, Stretton A, Morgan AR, Lovestone S, ... ... Love S, et al. Erratum: Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease Nature Genetics. 41: 1156-1156. DOI: 10.1038/Ng1009-1156D  0.312
2008 Boche D, Zotova E, Weller RO, Love S, Neal JW, Pickering RM, Wilkinson D, Holmes C, Nicoll JA. Consequence of Abeta immunization on the vasculature of human Alzheimer's disease brain. Brain : a Journal of Neurology. 131: 3299-310. PMID 18953056 DOI: 10.1093/Brain/Awn261  0.376
2008 Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, Bullock R, Love S, Neal JW, Zotova E, Nicoll JA. Long-term effects of Abeta42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet. 372: 216-23. PMID 18640458 DOI: 10.1016/S0140-6736(08)61075-2  0.381
2008 Miners JS, Baig S, Palmer J, Palmer LE, Kehoe PG, Love S. Abeta-degrading enzymes in Alzheimer's disease. Brain Pathology (Zurich, Switzerland). 18: 240-52. PMID 18363935 DOI: 10.1111/J.1750-3639.2008.00132.X  0.367
2008 Love S, Kehoe PG. Clearance of Abeta from the brain in Alzheimer's disease. Foreword. Brain Pathology (Zurich, Switzerland). 18: 239. PMID 18363934 DOI: 10.1111/J.1750-3639.2008.00131.X  0.384
2008 Fraser T, Tayler H, Love S. Low-temperature improved-throughput method for analysis of brain fatty acids and assessment of their post-mortem stability. Journal of Neuroscience Methods. 169: 135-40. PMID 18201768 DOI: 10.1016/J.Jneumeth.2007.12.001  0.305
2008 Miners JS, Ashby E, Van Helmond Z, Chalmers KA, Palmer LE, Love S, Kehoe PG. Angiotensin-converting enzyme (ACE) levels and activity in Alzheimer's disease, and relationship of perivascular ACE-1 to cerebral amyloid angiopathy. Neuropathology and Applied Neurobiology. 34: 181-93. PMID 17973905 DOI: 10.1111/J.1365-2990.2007.00885.X  0.392
2008 Baig S, Kehoe PG, Love S. MMP-2, -3 and -9 levels and activity are not related to Abeta load in the frontal cortex in Alzheimer's disease. Neuropathology and Applied Neurobiology. 34: 205-15. PMID 17971072 DOI: 10.1111/J.1365-2990.2007.00897.X  0.328
2008 Miners JS, Verbeek MM, Rikkert MO, Kehoe PG, Love S. Immunocapture-based fluorometric assay for the measurement of neprilysin-specific enzyme activity in brain tissue homogenates and cerebrospinal fluid. Journal of Neuroscience Methods. 167: 229-36. PMID 17904641 DOI: 10.1016/J.Jneumeth.2007.08.012  0.311
2008 Miners S, Ashy E, Love S, Kehoe P. P3-338: ACE protein and enzyme activity levels in brain and CSF in Alzheimer's disease: Influence of disease severity and ACE-1 genotype Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1907  0.364
2008 Palmer JC, Love S, Kehoe PG. P1-459: Endothelin-converting enzyme-1 and -2 levels are increased in Alzheimer's disease Alzheimers & Dementia. 4. DOI: 10.1016/J.Jalz.2008.05.1042  0.33
2007 Chalmers KA, Love S. Phosphorylated Smad 2/3 colocalizes with phospho-tau inclusions in Pick disease, progressive supranuclear palsy, and corticobasal degeneration but not with alpha-synuclein inclusions in multiple system atrophy or dementia with Lewy bodies. Journal of Neuropathology and Experimental Neurology. 66: 1019-26. PMID 17984683 DOI: 10.1097/Nen.0B013E31815885Ad  0.354
2007 Ballard CG, Chalmers KA, Todd C, McKeith IG, O'Brien JT, Wilcock G, Love S, Perry EK. Cholinesterase inhibitors reduce cortical Abeta in dementia with Lewy bodies. Neurology. 68: 1726-9. PMID 17502555 DOI: 10.1212/01.Wnl.0000261920.03297.64  0.375
2007 van Helmond ZK, Miners JS, Bednall E, Chalmers KA, Zhang Y, Wilcock GK, Love S, Kehoe PG. Caveolin-1 and -2 and their relationship to cerebral amyloid angiopathy in Alzheimer's disease. Neuropathology and Applied Neurobiology. 33: 317-27. PMID 17493012 DOI: 10.1111/J.1365-2990.2006.00815.X  0.423
2007 Chalmers KA, Love S. Neurofibrillary tangles may interfere with Smad 2/3 signaling in neurons. Journal of Neuropathology and Experimental Neurology. 66: 158-67. PMID 17279001 DOI: 10.1097/Nen.0B013E3180303B93  0.374
2007 Culpan D, Cornish A, Love S, Kehoe PG, Wilcock GK. Protein and gene expression of tumour necrosis factor receptors I and II and their promoter gene polymorphisms in Alzheimer's disease. Experimental Gerontology. 42: 538-44. PMID 17267158 DOI: 10.1016/J.Exger.2006.12.001  0.355
2006 Miners JS, Van Helmond Z, Chalmers K, Wilcock G, Love S, Kehoe PG. Decreased expression and activity of neprilysin in Alzheimer disease are associated with cerebral amyloid angiopathy. Journal of Neuropathology and Experimental Neurology. 65: 1012-21. PMID 17021406 DOI: 10.1097/01.Jnen.0000240463.87886.9A  0.426
2006 Culpan D, Prince JA, Matthews S, Palmer L, Hughes A, Love S, Kehoe PG, Wilcock GK. Neither sequence variation in the IL-10 gene promoter nor presence of IL-10 protein in the cerebral cortex is associated with Alzheimer's disease. Neuroscience Letters. 408: 141-5. PMID 16973274 DOI: 10.1016/J.Neulet.2006.08.068  0.313
2006 Miners J, Helmond Zv, Chalmers KA, Wilcock G, Love S, Kehoe PG. Reduced neprilysin expression in Alzheimer's disease is associated with APOE E4 and cerebral amyloid angiopathy Brain Pathology. PMID 16922993 DOI: 10.1111/J.1750-3639.2006.00019.X  0.387
2006 Love S, Siew LK, Dawbarn D, Wilcock GK, Ben-Shlomo Y, Allen SJ. Premorbid effects of APOE on synaptic proteins in human temporal neocortex. Neurobiology of Aging. 27: 797-803. PMID 15979210 DOI: 10.1016/J.Neurobiolaging.2005.04.008  0.365
2006 Miners JS, Helmond ZV, Chalmers K, Love S, Wilcock G, Kehoe P. P4-106: Reduced neprilysin expression in Alzheimer’s disease is associated with APOE ϵ4 and cerebral amyloid angiopathy Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1845  0.378
2006 Helmond ZKv, Miners JS, Chalmers KA, Zhang Y, Wilcock GK, Love S, Kehoe PG. P4-102: Caveolin-1 does not influence cerebrovascular accumulation Aβ in Alzheimer’s disease Alzheimers & Dementia. 2. DOI: 10.1016/J.Jalz.2006.05.1841  0.354
2006 Baig S, Wilcock G, Love S. Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease (vol 110, pg 393, 2005) Acta Neuropathologica. 112. DOI: 10.1007/S00401-006-0080-X  0.323
2005 Love S. Neuropathological investigation of dementia: a guide for neurologists. Journal of Neurology, Neurosurgery, and Psychiatry. 76: v8-14. PMID 16291923 DOI: 10.1136/Jnnp.2005.080754  0.344
2005 Chalmers K, Wilcock G, Love S. Contributors to white matter damage in the frontal lobe in Alzheimer's disease. Neuropathology and Applied Neurobiology. 31: 623-31. PMID 16281911 DOI: 10.1111/J.1365-2990.2005.00678.X  0.404
2005 Baig S, Wilcock GK, Love S. Loss of perineuronal net N-acetylgalactosamine in Alzheimer's disease. Acta Neuropathologica. 110: 393-401. PMID 16133543 DOI: 10.1007/S00401-005-1060-2  0.348
2005 Williams S, Chalmers K, Wilcock GK, Love S. Relationship of neurofibrillary pathology to cerebral amyloid angiopathy in Alzheimer's disease. Neuropathology and Applied Neurobiology. 31: 414-21. PMID 16008825 DOI: 10.1111/J.1365-2990.2005.00663.X  0.378
2005 Coore RR, Love S, McKinstry JL, Weaver HR, Philips A, Hillman T, Hiles M, Helps CR, Anil MH. Brain tissue fragments in jugular vein blood of cattle stunned by use of penetrating or nonpenetrating captive bolt guns. Journal of Food Protection. 68: 882-4. PMID 15830690 DOI: 10.4315/0362-028X-68.4.882  0.306
2005 Blomqvist ME, Chalmers K, Andreasen N, Bogdanovic N, Wilcock GK, Cairns NJ, Feuk L, Brookes AJ, Love S, Blennow K, Kehoe PG, Prince JA. Sequence variants of IDE are associated with the extent of beta-amyloid deposition in the Alzheimer's disease brain. Neurobiology of Aging. 26: 795-802. PMID 15718037 DOI: 10.1016/J.Neurobiolaging.2004.07.011  0.412
2005 Scolding NJ, Joseph F, Kirby PA, Mazanti I, Gray F, Mikol J, Ellison D, Hilton DA, Williams TL, MacKenzie JM, Xuereb JH, Love S. Abeta-related angiitis: primary angiitis of the central nervous system associated with cerebral amyloid angiopathy. Brain : a Journal of Neurology. 128: 500-15. PMID 15659428 DOI: 10.1093/Brain/Awh379  0.406
2004 Coore RR, Love S, McKinstry JL, Weaver HR, Phillips A, Hillman T, Hiles MJ, Shand A, Helps CR, Anil MH. Dissemination of brain emboli following captive bolt stunning of sheep: capacity for entry into the systemic arterial circulation. Journal of Food Protection. 67: 1050-2. PMID 15151250 DOI: 10.4315/0362-028X-67.5.1050  0.313
2004 Chalmers KA, Culpan D, Kehoe PG, Wilcock GK, Hughes A, Love S. APOE promoter, ACE1 and CYP46 polymorphisms and beta-amyloid in Alzheimer's disease. Neuroreport. 15: 95-8. PMID 15106838 DOI: 10.1097/00001756-200401190-00019  0.389
2004 Love S. Post mortem sampling of the brain and other tissues in neurodegenerative disease. Histopathology. 44: 309-17. PMID 15049895 DOI: 10.1111/J.1365-2559.2004.01794.X  0.358
2004 Katzov H, Chalmers K, Palmgren J, Andreasen N, Johansson B, Cairns NJ, Gatz M, Wilcock GK, Love S, Pedersen NL, Brookes AJ, Blennow K, Kehoe PG, Prince JA. Genetic variants of ABCA1 modify Alzheimer disease risk and quantitative traits related to beta-amyloid metabolism. Human Mutation. 23: 358-67. PMID 15024730 DOI: 10.1002/Humu.20012  0.375
2004 Chalmers KA, Culpan D, Kehoe PG, Wilcock GK, Hughes A, Love S. APOE promoter, ACE1 and CYP46 polymorphisms and β-amyloid in Alzheimer's disease Neuroreport. 15: 95-98. DOI: 10.1097/01.Wnr.0000096519.69073.Ee  0.392
2004 Culpan D, Cornish A, Kehoe PG, Love S, Wilcock GK. P3-203 TNFR-associated factor-2 (TRAF-2) expression in Alzheimer's disease Neurobiology of Aging. 25: 413-413. DOI: 10.1016/S0197-4580(04)81353-8  0.345
2004 Baig SM, Love S, Wilcock GK. P3-162 Loss of perineuronal nets in Alzheimer's disease is not related to tau pathology Neurobiology of Aging. 25. DOI: 10.1016/S0197-4580(04)81314-9  0.371
2004 Chalmers KA, Zhang Y, Love S, Wilcock GK, Kehoe PG. P1-210 The relationship between CAV-1 and cerebral amyloid angiopathy in Alzheimer's disease Neurobiology of Aging. 25: 156-156. DOI: 10.1016/S0197-4580(04)80523-2  0.389
2004 Love S. Acute haemorrhagic and hypoxic-ischaemic brain damage in the neonate Current Diagnostic Pathology. 10: 106-115. DOI: 10.1016/J.Cdip.2004.01.003  0.315
2003 Love S, Nicoll JA, Hughes A, Wilcock GK. APOE and cerebral amyloid angiopathy in the elderly. Neuroreport. 14: 1535-6. PMID 12960780 DOI: 10.1097/00001756-200308060-00027  0.392
2003 McCarron MO, Stewart J, McCarron P, Love S, Vinters HV, Ironside JW, Mann DM, Graham DI, Nicoll JA. Association between interleukin-1A polymorphism and cerebral amyloid angiopathy-related hemorrhage. Stroke; a Journal of Cerebral Circulation. 34: e193-5. PMID 12947160 DOI: 10.1161/01.Str.0000089294.85447.1E  0.331
2003 Chalmers K, Wilcock GK, Love S. APOE epsilon 4 influences the pathological phenotype of Alzheimer's disease by favouring cerebrovascular over parenchymal accumulation of A beta protein. Neuropathology and Applied Neurobiology. 29: 231-8. PMID 12787320 DOI: 10.1046/J.1365-2990.2003.00457.X  0.439
2001 Nicoll JA, Martin L, Stewart J, Murray LS, Love S, Kennedy PG. Involvement of apolipoprotein E in herpes simplex encephalitis. Neuroreport. 12: 695-8. PMID 11277566 DOI: 10.1097/00001756-200103260-00016  0.344
1999 McCarron MO, Nicoll JAR, Ironside JW, Love S, Alberts MJ, Bone I. Cerebral Amyloid Angiopathy–Related Hemorrhage Interaction of APOE ε2 With Putative Clinical Risk Factors Stroke. 30: 1643-1646. PMID 10436115 DOI: 10.1161/01.Str.30.8.1643  0.319
1999 McCarron MO, Nicoll JA, Stewart J, Ironside JW, Mann DM, Love S, Graham DI, Dewar D. The apolipoprotein E epsilon2 allele and the pathological features in cerebral amyloid angiopathy-related hemorrhage. Journal of Neuropathology and Experimental Neurology. 58: 711-8. PMID 10411341 DOI: 10.1097/00005072-199907000-00005  0.382
1999 Spillantini MG, Tolnay M, Love S, Goedert M. Microtubule-associated protein tau, heparan sulphate and alpha-synuclein in several neurodegenerative diseases with dementia. Acta Neuropathologica. 97: 585-94. PMID 10378377 DOI: 10.1007/S004010051034  0.357
1999 Love S, Barber R, Wilcock GK. Increased poly(ADP-ribosyl)ation of nuclear proteins in Alzheimer's disease. Brain : a Journal of Neurology. 122: 247-53. PMID 10071053 DOI: 10.1093/Brain/122.2.247  0.407
1997 Nicoll JA, Burnett C, Love S, Graham DI, Dewar D, Ironside JW, Stewart J, Vinters HV. High frequency of apolipoprotein E epsilon 2 allele in hemorrhage due to cerebral amyloid angiopathy. Annals of Neurology. 41: 716-21. PMID 9189032 DOI: 10.1002/Ana.410410607  0.369
1996 Love S, Wilcock GK, Matthews SM. No correlation between nigral degeneration and striatal plaques in Alzheimer's disease. Acta Neuropathologica. 91: 432-6. PMID 8928622 DOI: 10.1007/S004010050447  0.384
1995 Hilton DA, Love S, Ferguson I, Newman P. Motor neuron disease with neurofibrillary tangles in a non-Guamanian patient. Acta Neuropathologica. 90: 101-106. PMID 7572072 DOI: 10.1007/Bf00294466  0.371
1994 Murshid WR, Nelson RJ, Love S. Spontaneous cerebral haemorrhage from cerebral amyloid angiopathy. British Journal of Neurosurgery. 8: 457-460. PMID 7811411 DOI: 10.3109/02688699408995114  0.321
1992 Nicoll JAR, Kinrade E, Love S. PCR-mediated search for herpes simplex virus DNA in sections of brain from patients with multiple sclerosis and other neurological disorders Journal of the Neurological Sciences. 113: 144-151. PMID 1336795 DOI: 10.1016/0022-510X(92)90242-D  0.314
1992 Love S, Nicoll JAR. Comparison of modified Bielschowsky silver impregnation and anti-ubiquitin immunostaining of cortical and nigral Lewy bodies Neuropathology and Applied Neurobiology. 18: 585-592. PMID 1283205 DOI: 10.1111/J.1365-2990.1992.Tb00830.X  0.308
1989 Love S, Burrola P, Terry RD, Wiley CA. Immunoelectron microscopy of Alzheimer and Pick brain tissue labelled with the monoclonal antibody Alz-50. Neuropathology and Applied Neurobiology. 15: 223-31. PMID 2747843 DOI: 10.1111/J.1365-2990.1989.Tb01224.X  0.371
1988 Love S, Saitoh T, Quijada S, Cole GM, Terry RD. Alz-50, ubiquitin and tau immunoreactivity of neurofibrillary tangles, Pick bodies and Lewy bodies. Journal of Neuropathology and Experimental Neurology. 47: 393-405. PMID 2838588 DOI: 10.1097/00005072-198807000-00001  0.394
Show low-probability matches.